Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: IL-6 and PD-1 antibody blockade combination therapy regulate inflammation and T lymphocyte apoptosis in murine model of sepsis

Fig. 1

Kaplan–Meier curve showing the 7-day survival rates of the sham, CLP alone, CLP mice treated with anti-IL-6 antibodies, anti-PD-1 antibodies, or both anti-IL-6 and anti-PD-1 antibodies. The number of mice included in each group was as follows: Sham (n = 12), CLP (n = 12), Anti-IL-6 (n = 12), Anti-PD-1 (n = 12), and Anti-IL-6/PD-1 (n = 12). Log-rank test; p = 0.164 (except for sham mice)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us